Shopping Cart 0
Cart Subtotal
AED 0

Penn Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Penn Medicine, a subsidiary of University of Pennsylvania is a medical care institute that offers diagnosis and treatment services. The institute offers patient care services in areas of cancer, allergy and immunology, anesthesiology and critical care, bariatric surgery, behavioural health, transfusion-free medicine, colon and rectal surgery, dental, dermatology, ear, nose and throat, emergency medicine, endocrinology, diabetes and metabolism, fertility care, gastroenterology and geriatric medicine, among others. It offers medical educational services, and conducts research on several clinical services. The institute operates hospitals and specialty centers in Pennsylvania. Penn medicine is headquartered in Philadelphia, Pennsylvania, the US.

Penn Medicine-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Penn Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Penn Medicine, Medical Devices Deals, 2012 to YTD 2018 10

Penn Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Penn Medicine, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Carisma Therapeutics Raises USD53 Million in Series A Financing 12

Partnerships 14

Tempus Health Enters into Agreement with Penn Medicine 14

CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 15

Licensing Agreements 16

Dimension Therapeutics Enters into Licensing Agreement with Perelman School of Medicine at the University of Pennsylvania 16

Cetazam Therapeutics Enters into Licensing Agreement with Perelman School of Medicine 17

Equity Offering 18

Tmunity Therapeutics Raises USD10 Million in Equity Financing 18

Penn Medicine-Key Competitors 19

Penn Medicine-Key Employees 20

Penn Medicine-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 23

Government and Public Interest 23

Sep 07, 2018: Penn Medicine Researchers Receive Big Data Grant from NIH to Test New Approach for Personalized Breast Cancer Treatments 23

Aug 27, 2018: Additional inhibitor can help anti-VEGF therapy overcome resistance in deadly brain cancer 24

Aug 24, 2018: Scientists inch closer to universal flu vaccine 25

Aug 15, 2018: First-of-its-Kind Parkinson's Disease Biomarker Guidelines Invigorates Drive for Treatments 26

Aug 15, 2018: First mouse model to mimic lung disease could speed discovery of more effective treatments 27

Aug 06, 2018: Advancing Transplantation: Hepatitis C-infected Organs Safe for Transplantation When Followed by Antiviral Treatment 28

Aug 02, 2018: Machine Learning links major dimensions of mental illness in youth to abnormalities of brain networks 29

Jul 18, 2018: Cancer patients may experience delayed skin effects of Anti-PD-1 therapy 31

Jul 10, 2018: Aspirin Desensitization Improves Alcohol-Induced Allergies in Patients with Underlying Respiratory Disease 32

Jun 22, 2018: Penn Study Reveals New Therapeutic Target for Slowing the Spread of Flu Virus 33

Jun 21, 2018: Antifreeze Molecules May Stop and Reverse Damage from Brain Injuries 34

Jun 11, 2018: New Target for Treating Heart Failure Identified by Penn Medicine Researchers 35

May 23, 2018: Penn Researchers Identify Cellular Source of Molecule Implicated in Nasal Polyps, Asthma Attacks 36

Mar 10, 2018: Precision Medicine: Access to Real-time Genetic Testing Data Impacts Prescriber Behavior following Minimally Invasive Stent Procedure 37

Feb 28, 2018: New-found Stem Cell Helps Regenerate Lung Tissue after Acute Injury, Finds Penn Study 38

Feb 27, 2018: Gene-editing Reduces Triglycerides, Cholesterol by Up to 50 Percent, Finds Penn Animal Study 39

Feb 19, 2018: Brain Immune System is Key to Recovery from Motor Neuron Degeneration 40

Feb 19, 2018: Highly Mutated Protein in Skin Cancer Plays Central Role in Skin Cell Renewal 41

Feb 14, 2018: University of Pennsylvania Researchers Conduct Comprehensive Evaluation of Patients with Concussion-Like Symptoms Following Reports of Audible Phenomena in Cuba 42

Jan 24, 2018: Penn Center for Inherited Cardiovascular Disease Gifted USD 5 Million 43

Jan 16, 2018: Penn Researchers Identify New Treatment Target for Melanoma 44

Dec 15, 2017: Penn Researcher Receives USD 4M State Award for Multi-Institution Effort to Transform Prevention, Diagnosis, and Treatment of Traumatic Brain Injury 46

Dec 11, 2017: CAR T, Immunotherapy Bring New Hope for Multiple Myeloma Patients 47

Oct 23, 2017: Proton Therapy Lowers Treatment Side Effects in Pediatric Head and Neck Cancer Patients 49

Feb 08, 2017: Penn Genetics Researcher Receives Grant from Pharmaceutical Consortium to Study Diabetic Kidney Disease 50

Product News 51

Nov 07, 2017: Paving a New Path to Parenthood: Penn Medicine Launches First Clinical Trial for Uterine Transplant in the Northeast 51

Aug 09, 2018: Drugs in development for cancer May also fight brain diseases, including ALS 53

Jun 27, 2018: Penn Study Reveals Secrets of Hot and Cold Pancreatic Cancer Tumors 54

Apr 11, 2018: Personalized Tumor Vaccine Shows Promise in Pilot Trial 55

Mar 22, 2018: Boosting Enzyme May Help Improve Blood Flow, Fitness in Elderly 56

Other Significant Developments 58

Jun 05, 2018: Penn Medicine Gastrointestinal Bleeding Research Points to Need for Updated Medicare Policies 58

Jan 19, 2017: New ChimerMarker software version enhances workflow at Penn Medicine 60

Appendix 61

Methodology 61

About GlobalData 61

Contact Us 61

Disclaimer 61


List Of Figure

List of Figures

Penn Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Penn Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Penn Medicine, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Penn Medicine, Pharmaceuticals & Healthcare, Key Facts 2

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Penn Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Penn Medicine, Deals By Therapy Area, 2012 to YTD 2018 9

Penn Medicine, Medical Devices Deals, 2012 to YTD 2018 10

Penn Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Carisma Therapeutics Raises USD53 Million in Series A Financing 12

Tempus Health Enters into Agreement with Penn Medicine 14

CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 15

Dimension Therapeutics Enters into Licensing Agreement with Perelman School of Medicine at the University of Pennsylvania 16

Cetazam Therapeutics Enters into Licensing Agreement with Perelman School of Medicine 17

Tmunity Therapeutics Raises USD10 Million in Equity Financing 18

Penn Medicine, Key Competitors 19

Penn Medicine, Key Employees 20

Penn Medicine, Other Locations 21

Penn Medicine, Subsidiaries 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Penn Medicine, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Penn Medicine, a subsidiary of University of Pennsylvania is a medical care institute that offers diagnosis and treatment services. The institute offers patient care services in areas of cancer, allergy and immunology, anesthesiology and critical care, bariatric surgery, behavioural health, transfusion-free medicine, colon and rectal surgery, dental, dermatology, ear, nose and throat, emergency medicine, endocrinology, diabetes and metabolism, fertility care, gastroenterology and geriatric medicine, among others. It offers medical educational services, and conducts research on several clinical services. The institute operates hospitals and specialty centers in Pennsylvania. Penn medicine is headquartered in Philadelphia, Pennsylvania, the US.

Penn Medicine-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Penn Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Penn Medicine, Medical Devices Deals, 2012 to YTD 2018 10

Penn Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Penn Medicine, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Carisma Therapeutics Raises USD53 Million in Series A Financing 12

Partnerships 14

Tempus Health Enters into Agreement with Penn Medicine 14

CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 15

Licensing Agreements 16

Dimension Therapeutics Enters into Licensing Agreement with Perelman School of Medicine at the University of Pennsylvania 16

Cetazam Therapeutics Enters into Licensing Agreement with Perelman School of Medicine 17

Equity Offering 18

Tmunity Therapeutics Raises USD10 Million in Equity Financing 18

Penn Medicine-Key Competitors 19

Penn Medicine-Key Employees 20

Penn Medicine-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 23

Government and Public Interest 23

Sep 07, 2018: Penn Medicine Researchers Receive Big Data Grant from NIH to Test New Approach for Personalized Breast Cancer Treatments 23

Aug 27, 2018: Additional inhibitor can help anti-VEGF therapy overcome resistance in deadly brain cancer 24

Aug 24, 2018: Scientists inch closer to universal flu vaccine 25

Aug 15, 2018: First-of-its-Kind Parkinson's Disease Biomarker Guidelines Invigorates Drive for Treatments 26

Aug 15, 2018: First mouse model to mimic lung disease could speed discovery of more effective treatments 27

Aug 06, 2018: Advancing Transplantation: Hepatitis C-infected Organs Safe for Transplantation When Followed by Antiviral Treatment 28

Aug 02, 2018: Machine Learning links major dimensions of mental illness in youth to abnormalities of brain networks 29

Jul 18, 2018: Cancer patients may experience delayed skin effects of Anti-PD-1 therapy 31

Jul 10, 2018: Aspirin Desensitization Improves Alcohol-Induced Allergies in Patients with Underlying Respiratory Disease 32

Jun 22, 2018: Penn Study Reveals New Therapeutic Target for Slowing the Spread of Flu Virus 33

Jun 21, 2018: Antifreeze Molecules May Stop and Reverse Damage from Brain Injuries 34

Jun 11, 2018: New Target for Treating Heart Failure Identified by Penn Medicine Researchers 35

May 23, 2018: Penn Researchers Identify Cellular Source of Molecule Implicated in Nasal Polyps, Asthma Attacks 36

Mar 10, 2018: Precision Medicine: Access to Real-time Genetic Testing Data Impacts Prescriber Behavior following Minimally Invasive Stent Procedure 37

Feb 28, 2018: New-found Stem Cell Helps Regenerate Lung Tissue after Acute Injury, Finds Penn Study 38

Feb 27, 2018: Gene-editing Reduces Triglycerides, Cholesterol by Up to 50 Percent, Finds Penn Animal Study 39

Feb 19, 2018: Brain Immune System is Key to Recovery from Motor Neuron Degeneration 40

Feb 19, 2018: Highly Mutated Protein in Skin Cancer Plays Central Role in Skin Cell Renewal 41

Feb 14, 2018: University of Pennsylvania Researchers Conduct Comprehensive Evaluation of Patients with Concussion-Like Symptoms Following Reports of Audible Phenomena in Cuba 42

Jan 24, 2018: Penn Center for Inherited Cardiovascular Disease Gifted USD 5 Million 43

Jan 16, 2018: Penn Researchers Identify New Treatment Target for Melanoma 44

Dec 15, 2017: Penn Researcher Receives USD 4M State Award for Multi-Institution Effort to Transform Prevention, Diagnosis, and Treatment of Traumatic Brain Injury 46

Dec 11, 2017: CAR T, Immunotherapy Bring New Hope for Multiple Myeloma Patients 47

Oct 23, 2017: Proton Therapy Lowers Treatment Side Effects in Pediatric Head and Neck Cancer Patients 49

Feb 08, 2017: Penn Genetics Researcher Receives Grant from Pharmaceutical Consortium to Study Diabetic Kidney Disease 50

Product News 51

Nov 07, 2017: Paving a New Path to Parenthood: Penn Medicine Launches First Clinical Trial for Uterine Transplant in the Northeast 51

Aug 09, 2018: Drugs in development for cancer May also fight brain diseases, including ALS 53

Jun 27, 2018: Penn Study Reveals Secrets of Hot and Cold Pancreatic Cancer Tumors 54

Apr 11, 2018: Personalized Tumor Vaccine Shows Promise in Pilot Trial 55

Mar 22, 2018: Boosting Enzyme May Help Improve Blood Flow, Fitness in Elderly 56

Other Significant Developments 58

Jun 05, 2018: Penn Medicine Gastrointestinal Bleeding Research Points to Need for Updated Medicare Policies 58

Jan 19, 2017: New ChimerMarker software version enhances workflow at Penn Medicine 60

Appendix 61

Methodology 61

About GlobalData 61

Contact Us 61

Disclaimer 61


List Of Figure

List of Figures

Penn Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Penn Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Penn Medicine, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Penn Medicine, Pharmaceuticals & Healthcare, Key Facts 2

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Penn Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Penn Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Penn Medicine, Deals By Therapy Area, 2012 to YTD 2018 9

Penn Medicine, Medical Devices Deals, 2012 to YTD 2018 10

Penn Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Carisma Therapeutics Raises USD53 Million in Series A Financing 12

Tempus Health Enters into Agreement with Penn Medicine 14

CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 15

Dimension Therapeutics Enters into Licensing Agreement with Perelman School of Medicine at the University of Pennsylvania 16

Cetazam Therapeutics Enters into Licensing Agreement with Perelman School of Medicine 17

Tmunity Therapeutics Raises USD10 Million in Equity Financing 18

Penn Medicine, Key Competitors 19

Penn Medicine, Key Employees 20

Penn Medicine, Other Locations 21

Penn Medicine, Subsidiaries 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Penn Medicine, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.